Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Adefovir is a potent nucleotide analog inhibitor of hepatitis B virus (HBV) DNA polymerase. Its oral prodrug adefovir dipivoxil has been approved for the treatment of chronic HBV infection. In this study, adefovir was characterized for its in vitro effects on mitochondrial DNA (mtDNA) synthesis and ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1046/j.1365-2893.2003.00399.x
データ提供:米国国立医学図書館(NLM)
Adefovir: A Oasis in the Desert of Hepatitis B Treatment
This study delves into the intricate world of [antiviral therapy] for [hepatitis B virus (HBV) infection]. It's like a scientific expedition through a desert of viral challenges, seeking effective treatments to combat this persistent threat. The researchers explored the potential impact of [adefovir], a potent nucleotide analog inhibitor of HBV DNA polymerase, on [mitochondrial DNA (mtDNA) synthesis] in both liver and skeletal muscle cells.
A Safe Oasis in the Desert of Antiviral Treatment
Their findings demonstrate that adefovir, like a refreshing oasis in the desert of antiviral therapy, does not significantly affect mtDNA synthesis at clinically relevant concentrations. This is a crucial finding, as [mtDNA depletion] can lead to serious side effects. In contrast, other nucleoside analogues, such as [fialuridine (FIAU)] and [zalcitabine (ddC)], showed significant [mtDNA reduction]. This reinforces the importance of selecting [antiviral medications] that are both effective and safe for patients with HBV infection.
Navigating the Desert of HBV Treatment: A Guide for Clinicians and Patients
This study, like a reliable guide through a desert, provides valuable information for clinicians and patients managing HBV infection. It underscores the importance of understanding the [potential side effects] associated with different antiviral medications. This research can help clinicians make informed decisions about treatment options, minimizing the risk of [mtDNA depletion] and ensuring the best possible outcomes for patients.
Dr. Camel's Conclusion
This study, like a hidden oasis in the desert of HBV treatment, highlights the importance of selecting medications that are not only effective but also safe for patients. It's a reminder that even in the most challenging medical landscapes, there are often safe and effective solutions waiting to be discovered.
Date :
- Date Completed 2003-05-27
- Date Revised 2019-11-06
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.